VEGF-D

VEGF-D

VEGF-D 분자 정보

Molecule Name
Vascular endothelial growth factor D
분자 별명
FIGF,VEGFD
Drug Development Progress
임상 약물 수2
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D),FIGF,c-Fos-induced growth factor,VEGFD,VEGF-D,Vascular Endothelial Growth Factor D
분자 배경
Vascular endothelial growth factor D (VEGF-D) is also known as C-fos induced growth factor (FIGF), which belongs to the PDGF / VEGF growth factor family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. This secreted protein VEGF-D / FIGF undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-2 and VEGFR-3. The structure and function of this protein is similar to those of VEGFC. FIGF / VEGF-D is highly expressed in lung, heart, small intestine and fetal lung. FIGF / VEGF-D may function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR / FLK1) and VEGFR-3 (FLT4) receptors.

VEGF-D 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
EG-016EG-016; Ad-VEGF-APhase 2 ClinicalArk Therapeutics Ltd
Peripheral Vascular Diseases
상세
EG-011EG-011; Ad-VEGF-DPhase 2 ClinicalArk Therapeutics Ltd
Angina Pectoris
상세